Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Corrigendum to A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir.: Journal of Clinical Virology 174 (2024) 105711.

Lumley SF. et al, (2024), Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 174

Social, clinical and biological barriers to hepatitis B virus suppression with nucleos/tide analogue therapy: who is at risk and what should we do about it?

Im YR. et al, (2024), Sexually transmitted infections, 100, 259 - 263

A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir.

Lumley SF. et al, (2024), J Clin Virol, 174

Multiple risk factors for persistent HBV viraemia in an adult receiving nucleos/tide analogue therapy.

Lumley S. et al, (2024), Sexually transmitted infections

Peer support for people living with hepatitis B virus-A foundation for treatment expansion.

Downs LO. et al, (2024), Journal of viral hepatitis

Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection.

Delphin M. et al, (2024), The lancet. Gastroenterology & hepatology

Evaluation of sequence hybridization for respiratory viruses using the Twist Bioscience Respiratory Virus Research panel and the OneCodex Respiratory Virus sequence analysis workflow.

Kapel N. et al, (2023), Microbial genomics, 9

Include forthcoming?